(RGLS) Regulus Therapeutics - Performance 21.6% in 12m

Compare RGLS with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?

Performance Rating -53.48%
#80 in Group
Rel. Strength 77.44%
#1813 in Universe
Total Return 12m 21.59%
#36 in Group
Total Return 5y -41.28%
#57 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -0.04
54th Percentile in Group
FCF Yield -53.74%
10th Percentile in Group

12m Total Return: RGLS (21.6%) vs XBI (-2.3%)

Compare overall performance (total returns) of Regulus Therapeutics with its related sector ETF XBI

5y Drawdown (Underwater) Chart

5 Year Drawdown / Underwater Chart for (RGLS) Regulus Therapeutics - Performance 21.6% in 12m

Top Performers in Biotechnology

Short Term
Symbol 1w 1m 3m
RGLS 37.3% 112% 132%
RGC 0.03% -31.7% 608%
CRVO -7.05% -2.37% 289%
DBVT -4.26% 113% 88.7%
Long Term
Symbol 6m 12m 5y
RGLS 91.7% 21.6% -41.3%
DRUG -33.2% 2,901% 21.2%
RGC 524% 442% 176%
MNPR 152% 1,260% 19.5%
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol 1m 12m 5y P/E P/E Forward PEG EPS
Stability
EPS
CAGR
UTHR NASDAQ
United Therapeutics
-8% 23.5% 161% 11.9 10.6 1.43 83.8% 78.5%
HLN NYSE
Haleon
2.55% 23.2% 41.6% 24.7 20.3 1.8 27.1% -
AMGN NASDAQ
Amgen
-8.48% 7.43% 35.1% 36.6 13.3 0.94 -18.8% -20%
LONN SW
Lonza
0.56% 12.5% 38.1% 60.7 31.7 1.15 12.6% -10.3%
BIM PA
Biomerieux
-1.7% 17.1% 0.22% 31 24.2 1.45 -58.7% -25.1%
NBIX NASDAQ
Neurocrine Biosciences
-8.13% -22.5% 4.98% 30.8 20.4 0.27 61.5% 31.6%
KMDA NASDAQ
Kamada
-5.51% 32.3% -8.24% 24.3 22.8 0.91 47.7% 3.93%
ERF PA
Eurofins Scientific SE
6.82% -5.27% 21% 24.3 11.7 0.58 -70.8% -17.1%

Performance Comparison: RGLS vs XBI vs S&P 500

XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for RGLS
Total Return (including Dividends) RGLS XBI S&P 500
1 Month 112.31% -7.84% -4.31%
3 Months 131.93% -13.34% -7.85%
12 Months 21.59% -2.25% 10.76%
5 Years -41.28% -18.04% 106.31%
Trend Score (consistency of price movement) RGLS XBI S&P 500
1 Month 77.6% -17.6% -35.6%
3 Months 92.7% -91.9% -89.7%
12 Months -60.5% -36.5% 58.3%
5 Years -76.8% -53.3% 84.2%
Relative Strength (compared with Indexes) Rank in Peer Group vs. XBI vs. S&P 500
1 Month #2 130% 122%
3 Month #2 168% 152%
12 Month #38 24.4% 9.78%
5 Years #55 -28.4% -71.5%

FAQs

Does RGLS Regulus Therapeutics outperforms the market?

Yes, over the last 12 months RGLS made 21.59%, while its related Sector, the SPDR S&P Biotech (XBI) made -2.25%.
Over the last 3 months RGLS made 131.93%, while XBI made -13.34%.

Performance Comparison RGLS vs Indeces and Sectors

RGLS vs. Indices RGLS is Over or Underperforming

Symbol 1w 1m 6m 12m
US S&P 500 SPY 30.2% 117% 96.0% 10.8%
US NASDAQ 100 QQQ 28.2% 117% 96.0% 9.58%
US Dow Jones Industrial 30 DIA 32.2% 118% 95.7% 14.6%
German DAX 40 DAX 32.8% 116% 77.5% -1.92%
Shanghai Shenzhen CSI 300 CSI 300 36.7% 116% 97.4% 13.0%
Hongkong Hang Seng HSI 32.4% 115% 94.1% 7.57%
India NIFTY 50 INDA 37.6% 111% 94.4% 19.8%
Brasil Bovespa EWZ 30.4% 110% 91.5% 27.1%

RGLS vs. Sectors RGLS is Over or Underperforming

Symbol 1w 1m 6m 12m
Communication Services XLC 30.3% 118% 87.2% -0.81%
Consumer Discretionary XLY 27.8% 116% 92.8% 7.24%
Consumer Staples XLP 37.6% 110% 90.7% 12.1%
Energy XLE 33.5% 124% 98.4% 33.5%
Financial XLF 32.1% 117% 87.9% 2.29%
Health Care XLV 33.2% 117% 98.0% 21.3%
Industrial XLI 32.0% 116% 95.6% 14.7%
Materials XLB 33.4% 117% 103% 26.9%
Real Estate XLRE 35.0% 114% 98.1% 6.47%
Technology XLK 26.4% 117% 101% 15.4%
Utilities XLU 34.3% 111% 92.9% 1.15%
Aerospace & Defense XAR 30.6% 113% 84.7% -5.39%
Biotech XBI 31.0% 120% 109% 23.8%
Homebuilder XHB 31.9% 118% 111% 29.6%
Retail XRT 33.0% 115% 100% 25.2%

RGLS vs. Commodities RGLS is Over or Underperforming

Symbol 1w 1m 6m 12m
Oil USO 36.7% 120% 98.7% 35.8%
Natural Gas UNG 39.3% 135% 83.0% 12.3%
Gold GLD 40.8% 103% 71.4% -19.5%
Silver SLV 36.4% 114% 93.6% 1.68%
Copper CPER 35.3% 119% 80.9% 14.5%

RGLS vs. Yields & Bonds RGLS is Over or Underperforming

Symbol 1w 1m 6m 12m
iShares 20+ Years Bond TLT 34.0% 113% 93.2% 16.1%
iShares High Yield Corp. Bond HYG 35.4% 113% 89.4% 12.2%